清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

Anti-inflammatory Fucoidan-ConA oral insulin nanosystems for smart blood glucose regulation

褐藻糖胶 胰岛素 药理学 制药技术 化学 医学 多糖 内分泌学 生物化学 色谱法
作者
Jie Zhou,Huili Ma,Min Guan,Junfen Feng,Xiaorong Dong,Yuxin Wei,Tong Zhang
出处
期刊:International Journal of Pharmaceutics [Elsevier]
卷期号:: 124250-124250
标识
DOI:10.1016/j.ijpharm.2024.124250
摘要

The smart oral administration Insulin device has the potential to improve glycemic management. It can reduce the risk of hypoglycemia associated with exogenous Insulin (INS) therapy while also avoiding many of the disadvantages associated with subcutaneous injections. Furthermore, diabetes mellitus (DM) is an endocrine illness characterized by inflammation, and it is critical to minimize the amount of inflammatory markers in diabetic patients while maintaining average blood glucose. In this study, a responsive nanosystem vitamin B12-Fucoidan-Concanavalin A (VB12-FU-ConA NPs) with anti-inflammatory action was developed for smart oral delivery of Insulin. Con A has high sensitivity and strong specificity as a glucose-responsive material. Fucoidan has anti-inflammatory, immunomodulatory, and hypoglycemic functions, and it can bind to Con A to form a reversible complex. Under high glucose conditions, free glucose competitively binds to Con A, which swells the nanocarrier and promotes Insulin release. Furthermore, in the low pH environment of the gastrointestinal tract, positively charged VB12 and anionic fucoidan bind tightly to protect the Insulin wrapped in the carrier, and VB12 can also bind to intestinal epithelial factors to improve transit rate, thereby promoting INS absorption. In vitro tests showed that the release of nanoparticles in hyperglycemic solutions was significantly higher than the drug release in normoglycemic conditions. Oral delivery of the nanosystems dramatically lowered blood glucose levels in type I diabetic mice (T1DM) during in vivo pharmacodynamics, minimizing the risk of hypoglycemia. Blood glucose levels reached a minimum of 8.1 ± 0.4 mmol/L after 8 h. Administering the nanosystem orally notably decreased the serum levels of tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) in diabetic mice. The nano delivery system can be degraded and metabolized in the intestinal tract after being taken orally, demonstrating good biodegradability and biosafety. In conclusion, the present study showed that VB12-FU-ConA nanocarriers are expected to be a novel system for rationalizing blood glucose.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
9秒前
Stellarshi517发布了新的文献求助10
12秒前
muriel完成签到,获得积分10
14秒前
1分钟前
上官若男应助科研通管家采纳,获得10
1分钟前
2分钟前
肆肆完成签到,获得积分10
3分钟前
1437594843完成签到 ,获得积分10
3分钟前
姚老表完成签到,获得积分10
4分钟前
4分钟前
pp陶发布了新的文献求助10
4分钟前
隐形曼青应助pp陶采纳,获得10
4分钟前
kbcbwb2002完成签到,获得积分10
6分钟前
mengyuhuan完成签到 ,获得积分10
8分钟前
宇文非笑完成签到 ,获得积分10
8分钟前
8分钟前
9分钟前
spark810应助科研通管家采纳,获得10
9分钟前
9分钟前
9分钟前
9分钟前
9分钟前
luckbee完成签到,获得积分10
9分钟前
方白秋完成签到,获得积分10
10分钟前
spark810应助科研通管家采纳,获得10
11分钟前
spark810应助科研通管家采纳,获得10
11分钟前
11分钟前
11分钟前
xiewuhua完成签到,获得积分10
12分钟前
spark810应助科研通管家采纳,获得10
13分钟前
spark810应助科研通管家采纳,获得10
13分钟前
坚强的广山完成签到,获得积分0
14分钟前
15分钟前
pp陶发布了新的文献求助10
15分钟前
15分钟前
16分钟前
spark810应助科研通管家采纳,获得10
17分钟前
清净163完成签到,获得积分10
17分钟前
浮云完成签到 ,获得积分10
17分钟前
17分钟前
高分求助中
Evolution 2024
中国国际图书贸易总公司40周年纪念文集: 回忆录 2000
Impact of Mitophagy-Related Genes on the Diagnosis and Development of Esophageal Squamous Cell Carcinoma via Single-Cell RNA-seq Analysis and Machine Learning Algorithms 2000
Experimental investigation of the mechanics of explosive welding by means of a liquid analogue 1060
Die Elektra-Partitur von Richard Strauss : ein Lehrbuch für die Technik der dramatischen Komposition 1000
How to Create Beauty: De Lairesse on the Theory and Practice of Making Art 1000
Gerard de Lairesse : an artist between stage and studio 670
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3004777
求助须知:如何正确求助?哪些是违规求助? 2664111
关于积分的说明 7220003
捐赠科研通 2300612
什么是DOI,文献DOI怎么找? 1220158
科研通“疑难数据库(出版商)”最低求助积分说明 594574
版权声明 593226